Mediclinic International PLC (LON:MDC) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Mediclinic International PLC (LON:MDC) have been given an average rating of “Hold” by the seven analysts that are presently covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is GBX 411.80 ($5.38).

A number of brokerages recently commented on MDC. UBS Group reissued a “buy” rating and issued a GBX 395 ($5.16) price objective (down previously from GBX 410 ($5.36)) on shares of Mediclinic International in a research note on Friday, June 7th. HSBC reduced their price objective on shares of Mediclinic International from GBX 360 ($4.70) to GBX 310 ($4.05) and set a “hold” rating for the company in a research note on Thursday, June 20th. Barclays reduced their price objective on shares of Mediclinic International from GBX 460 ($6.01) to GBX 410 ($5.36) and set an “equal weight” rating for the company in a research note on Friday, April 12th. Finally, Bank of America raised shares of Mediclinic International to a “neutral” rating in a research note on Tuesday, June 4th.

Shares of LON:MDC opened at GBX 304.90 ($3.98) on Friday. The company has a market capitalization of $2.25 billion and a P/E ratio of -14.87. Mediclinic International has a 52 week low of GBX 293.10 ($3.83) and a 52 week high of GBX 549.40 ($7.18). The company has a quick ratio of 1.71, a current ratio of 1.86 and a debt-to-equity ratio of 63.47. The business has a 50 day simple moving average of GBX 315.67.

The firm also recently declared a dividend, which will be paid on Monday, July 29th. Stockholders of record on Thursday, June 13th will be given a dividend of GBX 4.70 ($0.06) per share. The ex-dividend date of this dividend is Thursday, June 13th. This is an increase from Mediclinic International’s previous dividend of $3.20. This represents a dividend yield of 1.43%. Mediclinic International’s dividend payout ratio is presently -0.39%.

Mediclinic International Company Profile

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 private acute care hospitals and 4 clinics with approximately 1,805 inpatient beds in Switzerland; 49 acute care private hospitals and 2 day clinics in South Africa, and 3 hospitals in Namibia with approximately 8,131 inpatient beds; and 6 acute care private hospitals and 22 clinics with approximately 748 inpatient beds in the United Arab Emirates.

Further Reading: What are the advantages of the Stochastic Momentum Index?

Analyst Recommendations for Mediclinic International (LON:MDC)

Receive News & Ratings for Mediclinic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International and related companies with's FREE daily email newsletter.